426 related articles for article (PubMed ID: 24189068)
21. The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma.
Holmes B; Benavides-Serrato A; Saunders JT; Landon KA; Schreck AJ; Nishimura RN; Gera J
J Neurooncol; 2019 Oct; 145(1):11-22. PubMed ID: 31473880
[TBL] [Abstract][Full Text] [Related]
22. The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
Serio J; Ropa J; Chen W; Mysliwski M; Saha N; Chen L; Wang J; Miao H; Cierpicki T; Grembecka J; Muntean AG
Oncogene; 2018 Jan; 37(4):450-460. PubMed ID: 28945229
[TBL] [Abstract][Full Text] [Related]
23. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.
Lu X; Fernando TM; Lossos C; Yusufova N; Liu F; Fontán L; Durant M; Geng H; Melnick J; Luo Y; Vega F; Moy V; Inghirami G; Nimer S; Melnick AM; Lossos IS
Blood; 2018 Nov; 132(19):2026-2039. PubMed ID: 30082494
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21
Chatterjee B; Ghosh K; Kanade SR
Biofactors; 2019 Sep; 45(5):818-829. PubMed ID: 31317586
[TBL] [Abstract][Full Text] [Related]
25. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.
Pal S; Vishwanath SN; Erdjument-Bromage H; Tempst P; Sif S
Mol Cell Biol; 2004 Nov; 24(21):9630-45. PubMed ID: 15485929
[TBL] [Abstract][Full Text] [Related]
26. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.
Pal S; Yun R; Datta A; Lacomis L; Erdjument-Bromage H; Kumar J; Tempst P; Sif S
Mol Cell Biol; 2003 Nov; 23(21):7475-87. PubMed ID: 14559996
[TBL] [Abstract][Full Text] [Related]
27. PRMT5 is required for cell-cycle progression and p53 tumor suppressor function.
Scoumanne A; Zhang J; Chen X
Nucleic Acids Res; 2009 Aug; 37(15):4965-76. PubMed ID: 19528079
[TBL] [Abstract][Full Text] [Related]
28. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
29. Mediator complex recruits epigenetic regulators via its two cyclin-dependent kinase subunits to repress transcription of immune response genes.
Tsutsui T; Fukasawa R; Shinmyouzu K; Nakagawa R; Tobe K; Tanaka A; Ohkuma Y
J Biol Chem; 2013 Jul; 288(29):20955-20965. PubMed ID: 23749998
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation.
Mileo AM; Mattarocci S; Matarrese P; Anticoli S; Abbruzzese C; Catone S; Sacco R; Paggi MG; Ruggieri A
J Exp Clin Cancer Res; 2015 Nov; 34():140. PubMed ID: 26576645
[TBL] [Abstract][Full Text] [Related]
31. Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression.
Saha K; Eckert RL
J Biol Chem; 2015 May; 290(21):13521-30. PubMed ID: 25851901
[TBL] [Abstract][Full Text] [Related]
32. PRMT5 promotes retinoblastoma development.
Jiang Y; Zheng G; Sun X
Hum Cell; 2023 Jan; 36(1):329-341. PubMed ID: 36331723
[TBL] [Abstract][Full Text] [Related]
33. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.
Rocha S; Martin AM; Meek DW; Perkins ND
Mol Cell Biol; 2003 Jul; 23(13):4713-27. PubMed ID: 12808109
[TBL] [Abstract][Full Text] [Related]
34. Notch Represses Transcription by PRC2 Recruitment to the Ternary Complex.
Han X; Ranganathan P; Tzimas C; Weaver KL; Jin K; Astudillo L; Zhou W; Zhu X; Li B; Robbins DJ; Capobianco AJ
Mol Cancer Res; 2017 Sep; 15(9):1173-1183. PubMed ID: 28584023
[TBL] [Abstract][Full Text] [Related]
35. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.
Yan F; Alinari L; Lustberg ME; Martin LK; Cordero-Nieves HM; Banasavadi-Siddegowda Y; Virk S; Barnholtz-Sloan J; Bell EH; Wojton J; Jacob NK; Chakravarti A; Nowicki MO; Wu X; Lapalombella R; Datta J; Yu B; Gordon K; Haseley A; Patton JT; Smith PL; Ryu J; Zhang X; Mo X; Marcucci G; Nuovo G; Kwon CH; Byrd JC; Chiocca EA; Li C; Sif S; Jacob S; Lawler S; Kaur B; Baiocchi RA
Cancer Res; 2014 Mar; 74(6):1752-65. PubMed ID: 24453002
[TBL] [Abstract][Full Text] [Related]
36. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.
Wei TY; Juan CC; Hisa JY; Su LJ; Lee YC; Chou HY; Chen JM; Wu YC; Chiu SC; Hsu CP; Liu KL; Yu CT
Cancer Sci; 2012 Sep; 103(9):1640-50. PubMed ID: 22726390
[TBL] [Abstract][Full Text] [Related]
37. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
38. The Kruppel-like zinc finger protein ZNF224 recruits the arginine methyltransferase PRMT5 on the transcriptional repressor complex of the aldolase A gene.
Cesaro E; De Cegli R; Medugno L; Florio F; Grosso M; Lupo A; Izzo P; Costanzo P
J Biol Chem; 2009 Nov; 284(47):32321-30. PubMed ID: 19741270
[TBL] [Abstract][Full Text] [Related]
39. Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2.
Enrico TP; Stallaert W; Wick ET; Ngoi P; Wang X; Rubin SM; Brown NG; Purvis JE; Emanuele MJ
Elife; 2021 Dec; 10():. PubMed ID: 34851822
[TBL] [Abstract][Full Text] [Related]
40. The carcinogen cadmium elevates CpG-demethylation and enrichment of NFYA and E2F1 in the promoter of oncogenic PRMT5 and EZH2 methyltransferases resulting in their elevated expression in vitro.
Ghosh K; Chatterjee B; Behera P; Kanade SR
Chemosphere; 2020 Mar; 242():125186. PubMed ID: 31675590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
